OS3.1 Antiepileptic drugs and their association with depression, anxiety and subjective cognitive impairment in glioma patients

بواسطة van der Meer, P B, Taphoorn, M J B, van den Bent, M J, Dirven, L, Koekkoek, J A F
الحاوية / القاعدة Neuro Oncol (2019)

OS3.6 Prediagnostic symptoms and signs of adult glioma: the patients’ view

بواسطة Peeters, M C M, Dirven, L, Koekkoek, J A F, Gortmaker, E G, Fritz, L, Vos, M J, Taphoorn, M J B
الحاوية / القاعدة Neuro Oncol (2019)

O9.08 END OF LIFE CARE IN HIGH-GRADE GLIOMA PATIENTS IN THREE EUROPEAN COUNTRIES: A COMPARATIVE STUDY

بواسطة Koekkoek, J.A.F., Dirven, L., Reijneveld, J.C., Pasman, H.R.W., McNamara, S., Grisold, W., Stockhammer, G., Marosi, C., Taphoorn, M.J.B., Heimans, J.J.
منشور في 2014

OS10.1 Survival analysis of IDH wildtype astrocytomas with molecular features of glioblastoma, WHO grade IV

بواسطة Tesileanu, C M S, Koekkoek, J A F, Dirven, L, Dubbink, H J, Kros, J M, van Duinen, S G, Smits, M, French, P J, Taphoorn, M J B, van den Bent, M J
الحاوية / القاعدة Neuro Oncol (2019)

Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study

بواسطة Kerkhof, M., Koekkoek, J. A. F., Vos, M. J., van den Bent, M. J., Taal, W., Postma, T. J., Bromberg, J. E. C., Kouwenhoven, M. C. M., Dirven, L., Reijneveld, J. C., Taphoorn, M. J. B.
الحاوية / القاعدة J Neurooncol (2019)